Carcinogenesis, Vol 19, 765-769, Copyright © 1998 by Oxford University Press
W Pan, T Sun, R Hoess and R Grafstrom
We have determined the minimal portion of the retinoblastoma protein (Rb)
that can serve as an efficient substrate for in vitro phosphorylation by
cdk4 kinase-D1 cyclin. Kinetic measurements indicate that in vitro, a
15-kDa fragment that represents the C-terminus of Rb can serve equally well
as a substrate when compared with the larger 56- kDa fragment of Rb, which
contains the A, B and C domains. By comparison, peptide substrates appear
to be 1000-fold less efficient. Furthermore, mutational analysis indicates
that not all of the five phosphorylation sites within this minimal C domain
are phosphorylated equally by cdk4/D1. Ser795 is the preferred
phosphorylation site, whereas the four remaining sites Ser807, Ser811,
Thr821 and Thr826 are phosphorylated to a much lesser degree. Truncations
of the C domain from the carboxy terminus indicate that almost all of this
domain is required for efficient phosphorylation. These data suggest that
the structural context of the phosphorylation site within the substrate is
critical for its phosphorylation by the cdk4/D1 kinase.
ARTICLES
Defining the minimal portion of the retinoblastoma protein that serves as an efficient substrate for cdk4 kinase/cyclin D1 complex
Genetics and Cancer Group, Dupont-Merck Pharmaceutical Co., Wilmington, DE 19880-0336, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. J. Day, A. Cleasby, I. J. Tickle, M. O'Reilly, J. E. Coyle, F. P. Holding, R. L. McMenamin, J. Yon, R. Chopra, C. Lengauer, et al. Crystal structure of human CDK4 in complex with a D-type cyclin PNAS, March 17, 2009; 106(11): 4166 - 4170. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M.R. Schmitz, A. Hirt, M. Aebi, and K. Leibundgut Limited Redundancy in Phosphorylation of Retinoblastoma Tumor Suppressor Protein by Cyclin-Dependent Kinases in Acute Lymphoblastic Leukemia Am. J. Pathol., September 1, 2006; 169(3): 1074 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huynh, K. C. Soo, P. K.H. Chow, L. Panasci, and E. Tran Xenografts of Human Hepatocellular Carcinoma: A Useful Model for Testing Drugs. Clin. Cancer Res., July 15, 2006; 12(14): 4306 - 4314. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wallace and K. L. Ball Docking-Dependent Regulation of the Rb Tumor Suppressor Protein by Cdk4 Mol. Cell. Biol., June 15, 2004; 24(12): 5606 - 5619. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Garnovskaya, Y. V. Mukhin, T. M. Vlasova, J. S. Grewal, M. E. Ullian, B. G. Tholanikunnel, and J. R. Raymond Mitogen-induced Rapid Phosphorylation of Serine 795 of the Retinoblastoma Gene Product in Vascular Smooth Muscle Cells Involves ERK Activation J. Biol. Chem., June 4, 2004; 279(23): 24899 - 24905. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Cloud, C. Rogers, T. L. Reza, U. Ziebold, J. R. Stone, M. H. Picard, A. M. Caron, R. T. Bronson, and J. A. Lees Mutant Mouse Models Reveal the Relative Roles of E2F1 and E2F3 In Vivo Mol. Cell. Biol., April 15, 2002; 22(8): 2663 - 2672. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Pan, S. Cox, R. H. Hoess, and R. H. Grafström A Cyclin D1/Cyclin-dependent Kinase 4 Binding Site within the C Domain of the Retinoblastoma Protein Cancer Res., April 1, 2001; 61(7): 2885 - 2891. [Abstract] [Full Text] |
||||
![]() |
P. D. Adams, X. Li, W. R. Sellers, K. B. Baker, X. Leng, J. W. Harper, Y. Taya, and W. G. Kaelin Jr. Retinoblastoma Protein Contains a C-terminal Motif That Targets It for Phosphorylation by Cyclin-cdk Complexes Mol. Cell. Biol., February 1, 1999; 19(2): 1068 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Grafstrom, W. Pan, and R. H. Hoess Defining the substrate specificity of cdk4 kinase–cyclin D1 complex Carcinogenesis, February 1, 1999; 20(2): 193 - 198. [Abstract] [Full Text] [PDF] |
||||






